17.01.2013 • News • Amgen • Biotechnology • biotech industry

Amgen to Build Biotech Manufacturing Plant in Singapore

Amgen, the world's largest biotechnology company, announced on Wednesday plans to build a new manufacturing plant in Singapore.

Thousand Oaks, California-based Amgen said it plans to invest around $200 million in the project, which will initially focus on the production of antibody-based drugs.

Construction, in the Tuas Biomedical Park area of Singapore, is expected to begin in the next few months.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Top-Feature